🏛️ Verified NIH Record • Updated 2025-09-24

Atacicept in Subjects With IgA Nephropathy (NCT04716231)

🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Vera Therapeutics, Inc.

🩺 Plain-English Summary (8th-Grade Level)

A Phase 3 Study with Atacicept in Subjects With IgA Nephropathy (ORIGIN 3)

Who can join: Review the eligibility criteria below.

Location: ORIGIN 3 Global Site Contact Information — Brisbane, California

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

  • ORIGIN 3 Global Site Contact Information — Brisbane, California

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗